You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

TESTOSTERONE CYPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Testosterone Cypionate patents expire, and what generic alternatives are available?

Testosterone Cypionate is a drug marketed by Am Regent, Cipla, Eugia Pharma, Hikma, Hikma Farmaceutica, Padagis Us, Rising, Sandoz, Sun Pharm Inds Ltd, Watson Labs, Watson Pharms Inc, Wilshire Pharms Inc, and Xiromed. and is included in fifteen NDAs.

The generic ingredient in TESTOSTERONE CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TESTOSTERONE CYPIONATE?
  • What are the global sales for TESTOSTERONE CYPIONATE?
  • What is Average Wholesale Price for TESTOSTERONE CYPIONATE?
Drug patent expirations by year for TESTOSTERONE CYPIONATE
Drug Prices for TESTOSTERONE CYPIONATE

See drug prices for TESTOSTERONE CYPIONATE

Recent Clinical Trials for TESTOSTERONE CYPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
Yale UniversityPhase 2
DendreonPhase 2

See all TESTOSTERONE CYPIONATE clinical trials

Pharmacology for TESTOSTERONE CYPIONATE
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for TESTOSTERONE CYPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 207742-001 Jun 16, 2017 AO RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Pharms Inc TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 086030-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hikma TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 090387-002 Jul 15, 2010 AO RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Eugia Pharma TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 211817-001 Oct 20, 2023 AO RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Sandoz TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 040615-002 Aug 10, 2006 AO RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Xiromed TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 215351-001 Apr 13, 2023 AO RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hikma Farmaceutica TESTOSTERONE CYPIONATE testosterone cypionate INJECTABLE;INJECTION 091244-001 May 1, 2012 AO RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

TESTOSTERONE CYPIONATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Testosterone Cypionate

Introduction to Testosterone Cypionate

Testosterone cypionate is a synthetic version of the naturally occurring hormone testosterone, administered via intramuscular injection to provide a slow and sustained release of testosterone into the bloodstream. This treatment is crucial for men experiencing low testosterone levels, helping to restore normal hormone levels and improve quality of life[2].

Market Size and Forecast

The testosterone cypionate market has been experiencing rapid and substantial growth in recent years. Projections indicate that this expansion will continue from 2023 to 2031, with the market showing a persistent upward trend in its dynamics. This growth is expected to result in strong growth rates throughout the forecasted period, indicating significant and noteworthy development in the market[1].

Drivers of Market Growth

Several factors are driving the growth of the testosterone cypionate market:

Increasing Awareness and Prevalence of Testosterone Deficiency

The rising awareness of testosterone deficiency and its health implications is driving more individuals to seek treatment. This, coupled with the increasing prevalence of hypogonadism among men aged 40 to 79, is a major factor fueling the demand for testosterone replacement therapy[3][4].

Aging Population

The aging population is another significant driver, as older men often experience a natural decline in testosterone production. This demographic shift is leading to an increased need for supportive therapies and diagnostic testing[3].

Advancements in Formulations and Delivery Methods

Recent advancements in drug formulations, such as newer injection techniques and longer-lasting formulations, are making treatment more convenient for patients. This enhances patient adherence and satisfaction, contributing to the market's growth[4].

Growing Acceptance of Hormonal Treatments

The growing acceptance of hormonal treatments in both men and women is also a key driver. As more people become aware of the benefits of testosterone therapy, the demand for products like testosterone cypionate is increasing[4].

Market Segmentation

The testosterone replacement therapy market, which includes testosterone cypionate, can be segmented in several ways:

Product Type

The injectables segment, which includes testosterone cypionate, is expected to dominate the market due to its higher bioavailability, affordability, and controlled, sustained release of testosterone[3].

Active Ingredient Type

Testosterone cypionate is predicted to grow at the fastest pace within the active ingredient segment due to its extensive application in medicine and great efficacy[3].

End User

Clinics are expected to hold the largest market share due to their specialized knowledge, dedicated services, and personalized treatment programs for hormone replacement therapy[3].

Regional Analysis

North America

North America is currently the leading market for testosterone cypionate, driven by a high prevalence of testosterone deficiency and an advanced healthcare infrastructure[4].

Asia-Pacific

The Asia-Pacific region is emerging as a significant market due to rising healthcare expenditures, increasing awareness of hormonal treatments, and a growing aging population[4].

Financial Trajectory

The global testosterone replacement therapy market, which includes testosterone cypionate, is projected to grow from USD 1.98 billion in 2023 to USD 2.93 billion by 2033, at a Compound Annual Growth Rate (CAGR) of 4.0%[3].

Key Financial Metrics

  • Market Size: The testosterone cypionate market is valued in the billions, with a projected CAGR of approximately 5% over the next several years[4].
  • Revenue Growth: The production and distribution of testosterone cypionate generate significant revenue, supporting various related industries such as manufacturing, logistics, and healthcare services[4].
  • Investment Opportunities: The market presents numerous opportunities for investment and development, driven by rising demand for effective testosterone therapy and ongoing innovations in treatment options[4].

Challenges and Opportunities

Regulatory Landscape

Evolving regulatory landscapes are impacting the testosterone cypionate market. Governments are focusing on ensuring the safety and efficacy of hormonal therapies, prompting companies to invest in compliance and quality assurance measures. These regulatory changes present both challenges and opportunities for market players[4].

Side Effects and Safety Concerns

While testosterone cypionate offers significant benefits, it also comes with potential side effects such as water retention, acne, mood swings, increased blood cells, and hair loss. Additionally, there are concerns about cardiovascular risks, although studies have been inconclusive[2][5].

Innovations and Trends

Personalized Medicine

The trend towards personalized medicine is making its mark on the testosterone cypionate market. Healthcare providers are increasingly tailoring treatment plans to individual patients based on genetic, lifestyle, and health factors, enhancing the effectiveness of testosterone therapy[4].

Telehealth Services

The rise of telehealth services is also influencing the market, making it easier for patients to access and manage their testosterone replacement therapy remotely[4].

Conclusion

The testosterone cypionate market is poised for continued growth, driven by rising demand for effective testosterone therapy, increasing awareness of testosterone deficiency, and ongoing innovations in treatment options. As healthcare systems evolve and patient awareness increases, this market presents numerous opportunities for investment and development.

Key Takeaways

  • The testosterone cypionate market is experiencing rapid growth due to increasing awareness and prevalence of testosterone deficiency.
  • The market is driven by the aging population, advancements in formulations, and growing acceptance of hormonal treatments.
  • North America leads the market, but the Asia-Pacific region is emerging as a significant player.
  • The market is expected to grow from USD 1.98 billion in 2023 to USD 2.93 billion by 2033.
  • Innovations in personalized medicine and telehealth services are enhancing the market.

FAQs

Q: What is testosterone cypionate used for? Testosterone cypionate is used to treat male hypogonadism, a condition characterized by low testosterone levels. It helps restore normal hormone levels, improving symptoms such as fatigue, low libido, and mood swings[2].

Q: How is testosterone cypionate administered? Testosterone cypionate is administered via intramuscular injection, typically into the gluteal muscles. It has a half-life of approximately eight days, providing a slow and sustained release of testosterone into the bloodstream[2][5].

Q: What are the common side effects of testosterone cypionate? Common side effects include water retention, acne, mood swings, increased blood cells, and hair loss. There are also concerns about cardiovascular risks, although studies have been inconclusive[2][5].

Q: What is the projected growth rate of the testosterone cypionate market? The market is expected to grow at a Compound Annual Growth Rate (CAGR) of approximately 5% over the next several years[4].

Q: Which region is leading the testosterone cypionate market? North America is currently the leading market for testosterone cypionate, driven by a high prevalence of testosterone deficiency and an advanced healthcare infrastructure[4].

Sources

  1. Market Research Intellect: Testosterone Cypionate Injection Market Size And Forecast
  2. Balance My Hormones: Testosterone Cypionate | How to get it, dosages, side effects and costs
  3. GlobeNewswire: Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033
  4. Market Research Intellect: Fueling Growth: The Expanding Testosterone Cypionate Market Landscape
  5. Pfizer Medical Information: DEPO®-TESTOSTERONE (testosterone cypionate) Patient information

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.